The Union Cabinet, chaired by the Prime Minister Narendra Modi has approved the continuation of the Biomedical Research Career Programme beyond its initial 10-year term from 2008-09 to 2018-19 to a new five year phase from 2019-20 to 2023-24.
According to an official release, government has approved the continuation of Biomedical Research Career Programme beyond its initial 10-year term from 2008-09 to 2018-19 to a new five year phase from 2019-20 to 2023-24. The programme is run by the Department of Biotechnology and UK- based biomedical research charity – Wellcome Trust. With the extension, the DBT would be increasing its commitment to the programme by two times, in comparison to that of the Welcome Trust. The total financial implication of the same will be Rs 1092 crore with DBT and WT contributing Rs 728 crore and Rs 364 crore respectively. In the last ten years, the programme has fulfilled its objectives of building and nurturing talent of highest global standards in cutting-edge biomedical research in India, which has led to important scientific breakthroughs and applications to meet societal needs.
It has enabled high quality Indian scientists working abroad to return to India and has increased the number of locations geographically within India where world-class biomedical research is undertaken. In the five-year extension phase, the programme would continue to build this capacity and also strengthen clinical research and work towards addressing important health challenges for India.